Back to Lung Cancer
NCT06629714
NCT06629714
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with cancer (specifically esophageal, stomach, gastroesophageal junction, or non-small cell lung cancer) confirmed through medical tests, tissue samples, and scans
- You have a good general level of physical functioning, scored at 80 or above on a standard medical scale (confirm with trial site)
- Your cancer cannot be removed by surgery and has either spread locally or to other parts of the body
- You have not yet received any systemic cancer treatments such as chemotherapy, targeted therapy, anti-angiogenic drugs, or immunotherapy
- You have at least one tumor that can be measured on scans, according to standard medical guidelines
- You are currently receiving or will be receiving a type of immunotherapy drug (PD-1/PD-L1 inhibitor), either alone or combined with chemotherapy
- You are willing and able to complete questionnaires, either on your own or with help from someone else
- You are 18 years of age or older
Who may not be able to join:
- Your cancer is driven by a specific gene mutation (confirm with trial site)
- You have had another type of cancer within the past 3 years
- You currently have an acute or ongoing mental health condition
- You are currently taking antidepressants, anti-anxiety medications, or other psychiatric medications
- You have previously participated in another clinical drug trial
- You have brain metastases (cancer that has spread to the brain) that are causing symptoms
- You have a significant intellectual disability or communication difficulties that would make participation very difficult
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Anhui Medical University
Registry
clinicaltrials_gov
Start date
16 October 2020
Est. completion
20 April 2025
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Cohort 1 & 2: Progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.